Age Shapes Synovial Biomarker Levels and Outcomes After ACL Surgery

A prospective cohort study of 100 patients undergoing ACL reconstruction analyzed preoperative synovial fluid biomarkers and patient-reported outcomes at a minimum of 5 years postoperatively. The study reported that increasing age was independently associated with lower TIMP-1 concentrations, worse long-term outcomes, and reduced likelihood of achieving minimally important clinical improvement in pain, function, and activity; several biomarkers (MIP-1beta, MMP-3, TIMP-2, bFGF) showed age-dependent associations with specific outcomes. The authors concluded that age modifies the prognostic significance of certain synovial biomarkers after ACL injury.

Most relevant for: Patients undergoing ACL reconstruction across a range of ages, particularly relevant to prognostic risk stratification based on preoperative synovial fluid biomarkers.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.